Peridot Capitalist

In today’s economic and financial market climate investors have to balance a stock market that is no longer cheap and an economy that has obvious structural damage. The consensus has concluded that below-average economic growth and employment could be with us for at least several more years. Given such circumstances we must be even more [...]

I recently did an interview with the investment site “Behind The Spread” which focused on learning about the backgrounds of various investment professionals.  They are interviewing the genius investors on KaChing and it was my turn in line. If you would like to learn a bit more about me and my investment philosophy, you can [...]

The U.S. stock market has rallied six percent so far this week after second quarter earnings have thus far boosted investor confidence. The four large companies getting the most attention this week have all surpassed estimates (Goldman Sachs, Intel, Johnson and Johnson, and Yum Brands).
It is hard to paint these results with anything but a [...]

The current bear market resulted in the first negative ten-year period for the U.S. stock market in a long time. This has prompted many people to declare that the investment strategy of buying and holding stocks for the long term (”buy and “hold” for short) is all of the sudden “dead” or no longer viable.
Personally, [...]

As my clients know well, I am a contrarian when it comes to investing in the market. To me, buying a stock is no different than shopping for a new house, car, or wardrobe at the mall. You get your best deals when you are either buying things other people don’t want (store sale racks, [...]

A common saying on Wall Street, and for good reason. Although the stock market has been acting very well in recent weeks and today’s 200-point gain is a good start to this week, I am not going to be bashful about taking some chips off of the table for my clients and you shouldn’t be [...]

You may have heard about Dendreon (DNDN), a small money losing biotechnology company that is in the process of getting its cancer vaccine, Provenge, approved by the FDA. Full results from a crucial phase three study were released yesterday afternoon in Chicago, but about half an hour prior to their release, shares of Dendreon fell [...]

To me this swine flu outbreak looks a lot like avian bird flu; fairly contained and overhyped. Of course anything is possible, but as Wall Street frets about swine flu (Dow futures are down 150 this morning), investors should be on the lookout for investment opportunities. Worries over bird flu led to numerous bargains, especially [...]

This is a common question many people are trying to figure out these days. Can they retire? If so, when? Will they have to work longer than they thought just a year or two ago? What kind of investment returns are required to retire when they want to? What are the best investment options to [...]

Regrettably I was out of town for several days and as a result it has been awhile since I’ve posted anything. So, I decided to give you all a conservative trade idea now that the market has had a huge run over the last four weeks. We are definitely getting overbought here, so tread carefully.
Anyway, [...]